Race Oncology Limited (“Race”) held a Melbourne Investor Briefing on the 20th of October 2022 during which Race’s CEO, Mr Phil Lynch and CSO, Dr Daniel Tillett provided an overview on recent activities and the Company’s future plans. The presentation  was  followed by an interactive Q+A.

 

We understand that some of our shareholders were not able to make the in person briefing, so we recorded the session to ensure all shareholders can share in the update.

 

Please view the video and ask us any questions you might have! Our team will endeavour to get back to all questions soon.